|
Article Excerpt Patent Pushes Company's Intellectual Property Portfolio of First-in-Class Technologies Past 70 Issued or Pending Patents
SAN DIEGO -- MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, today announced it has obtained patent protection for their latest issued European patent in several countries, including France, Germany, Switzerland, U.K., Ireland, Belgium, Luxembourg and Monaco. This patent covers next generation technology from MCET, targeting multibillion-dollar medical marketplace segments, including a range of serious autoimmune disorders such as type-1 diabetes and multiple sclerosis.
The patent, which was issued last month by the European Patent Office, is a milestone validation of the Company's business strategy to obtain broad, worldwide protection of its advanced immune modulation technologies and intellectual property. The patent has helped push the Company's IP portfolio past the 70 issued or pending patent...
|
|

More articles from Business Wire
Symyx Technologies Creates New Sensors Company., November 29, 2006 Quiksilver, Inc. Announces Mexican Joint Venture., November 29, 2006 Dollar General Board of Directors Declares Dividend., November 29, 2006 LeaseCompare.com Launches Commercial Auto Leasing to Help Small Busine..., November 29, 2006 Macrovision's New AdminStudio Packaging Solution Eases Windows Vista M..., November 29, 2006
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|